A key Grand Rapids ramp will now be closed for months after a semi crash Tuesday, causing significant traffic disruptions and requiring drivers to find new routes.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...

Iopofosine I 131 achieved an 80% response rate in relapsed/refractory Waldenstrom’s macroglobulinemia, with 56.4% achieving a major response, surpassing the trial's primary goal. The disease control ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The investigational targeted radiotherapy ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. I-131 apamistamab induced durable complete remissions ...

Iodine-131 (or I-131) is a radioactive substance that emits both beta and gamma radiation and has a half-life of 8.03 days. Under normal circumstances, there are low levels of I-131 present in the ...

Iopofosine-131 has been granted breakthrough therapy designation by the FDA for relapsed or refractory Waldenstrom macroglobulinemia, indicating its potential to improve treatment outcomes. The phase ...

Cellectar Biosciences has aligned with the FDA regarding the regulatory path for the potential accelerated approval of its drug iopofosine I 131 as a treatment for Waldenström macroglobulinemia (WM).